FindTrial
Sign In

A prospective randomized controlled trial for the Thoracoscopic Esophagectomy under Non-Carbon dioxide Artificial Pneumothorax versus traditional thoracoscopic procedure

A prospective randomized controlled trial for the Thoracoscopic Esophagectomy under Non-Carbon dioxide Artificial Pneumothorax versus traditional thoracoscopic procedure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025262
Enrollment
Unknown
Registered
2019-08-18
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Experimental group:Thoracoscopic esophagectomy under non-carbon dioxide artificial pneumothorax
Control group:Traditional thoracoscopic esophagectomy under carbon dioxide artificial pneumothorax

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Esophageal squamous cell carcinoma considered to be resectable.

Exclusion criteria

Exclusion criteria: 1. History of thoracic and abdominal surgery; 2. Receipt of any neoadjuvant radiotherapy, chemotherapy, or both; 3. Combined with other gastroesophageal diseases; 4. Patients refused to participate in clinical trials.

Design outcomes

Primary

MeasureTime frame
Level of folate receptor-positive circulating tumor cells (FR+CTCs);3-year overall survival;3-year disease-free survival;—

Secondary

MeasureTime frame
Time of surgery;Blood loss;Complications;—

Countries

China

Contacts

Public ContactWang Wenping

West China Hospital, Sichuan University

doctordipo@163.com+86 1366 812 4871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026